Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

植え付けられた血管義肢は,プロスタサイクリンを生成します.

H Sinzinger, K Silberbauer, M Winter

    Lancet (London, England)
    |October 14, 1978
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished.

    Thrombosis research·1995
    Same author

    Passive smoking and cardiovascular risk.

    Archives of internal medicine·1995
    Same author

    Gamma irradiation is not a novel approach to inhibit neointimal hyperplasia after arterial injury.

    Stroke·1995
    Same author

    Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy.

    Journal of cardiovascular pharmacology·1995
    Same author

    Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanning.

    Annals of the New York Academy of Sciences·1995
    Same author

    [1995 consensus guidelines for cholesterol. Society of Physicians in Vienna].

    Wiener klinische Wochenschrift·1995
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る